These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig. Gulino A; Pasqualini JR Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131 [TBL] [Abstract][Full Text] [Related]
6. 16 alpha-[77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors. Katzenellenbogen JA; Senderoff SG; McElvany KD; O'Brien HA; Welch MJ J Nucl Med; 1981 Jan; 22(1):42-7. PubMed ID: 6778976 [TBL] [Abstract][Full Text] [Related]
7. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981 [TBL] [Abstract][Full Text] [Related]
9. Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues. Yang DJ; Li C; Kuang LR; Price JE; Buzdar AU; Tansey W; Cherif A; Gretzer M; Kim EE; Wallace S Life Sci; 1994; 55(1):53-67. PubMed ID: 8015349 [TBL] [Abstract][Full Text] [Related]
10. Species-specific pharmacology of antiestrogens: role of metabolism. Jordan VC; Robinson SP Fed Proc; 1987 Apr; 46(5):1870-4. PubMed ID: 3556610 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Coezy E; Borgna JL; Rochefort H Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats. Feenstra A; Vaalburg W; Nolten GM; Reiffers S; Talma AG; Wiegman T; van der Molen HD; Woldring MG J Nucl Med; 1983 Jun; 24(6):522-8. PubMed ID: 6406650 [TBL] [Abstract][Full Text] [Related]
13. [I-125] 17 alpha-Iodovinyl 11 beta-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical. Jagoda EM; Gibson RE; Goodgold H; Ferreira N; Francis BE; Reba RC; Rzeszotarski WJ; Eckelman WC J Nucl Med; 1984 Apr; 25(4):472-7. PubMed ID: 6544817 [TBL] [Abstract][Full Text] [Related]
14. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079 [TBL] [Abstract][Full Text] [Related]
15. The stereoisomers of 17alpha-[123I]iodovinyloestradiol and its 11beta-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats. Rijks LJ; Boer GJ; Endert E; de Bruin K; van den Bos JC; van Doremalen PA; Schoonen WG; Janssen AG; van Royen EA Eur J Nucl Med; 1996 Mar; 23(3):295-307. PubMed ID: 8599961 [TBL] [Abstract][Full Text] [Related]
16. [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen]. Borgna JL; Rochefort H C R Seances Acad Sci D; 1979 Dec; 289(15):1141-4. PubMed ID: 121266 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy. Young H; Carnochan P; Trivedi M; Potter GA; Eccles SA; Haynes BP; Jarman M; Ott RJ Nucl Med Biol; 1995 May; 22(4):405-11. PubMed ID: 7550016 [TBL] [Abstract][Full Text] [Related]